Please login to the form below
RBW Consulting appoints researcher
Emma-Jane Lawson joins recruitment firm
RBW Consulting has appointed Emma-Jane Lawson to its healthcare communications team as researcher.
Lawson joins RBW as a graduate from the University of Kent where she completed an MA in applied linguistics.
She will assist head of healthcare communications Emma Thorp on the day-to-day running of RBW's key accounts, which include medical education, PR, advertising and digital clients.
Commenting on her appointment Lawson said: “I am thoroughly enjoying my time working within the healthcare communications team; it really is a fascinating area with so much to offer."
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Pfizer reports positive results for elranatamab in multiple myeloma
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- AstraZeneca to stop post-marketing study of Andexxa following early success
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by EC for older adults
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
